Data Bank for Eosinophilic Disorders

Clinical and Immunological Evaluation of Eosinophil Associated Gastrointestinal Disorders (EGID)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00267475

Enrollment

500

Registered

2005-12-21

Start date

2001-05-31

Completion date

2012-12-31

Last updated

2013-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteritis, Eosinophilic Colitis, Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Gastritis

Keywords

eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis, eosinophilic gastroenteritis

Brief summary

The purpose of this study is to conduct a translational study in patients with primary eosinophil associated gastrointestinal disorders \[EGID\] (e.g. eosinophilic esophagitis eosinophilic gastritis, eosinophilic enteritis \[EE\], eosinophilic colitis, and eosinophilic gastroenteritis \[EGE\]) with the aim of developing a data bank containing pertinent patient demographic information, tissue samples, and DNA, which will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

Patients with an eosinophil associated gastrointestinal disorder (EGID), family members of patients with EGID, or normal controls.

Countries

United States

Outcome results